Israel · Delayed Price · Currency is ILS · Price in ILA HomeBiogas Statistics
Total Valuation
HomeBiogas has a market cap or net worth of ILS 35.05 million. The enterprise value is 29.33 million.
| Market Cap | 35.05M |
| Enterprise Value | 29.33M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HomeBiogas has 43.98 million shares outstanding. The number of shares has increased by 35.05% in one year.
| Current Share Class | 43.98M |
| Shares Outstanding | 43.98M |
| Shares Change (YoY) | +35.05% |
| Shares Change (QoQ) | +15.53% |
| Owned by Insiders (%) | 17.08% |
| Owned by Institutions (%) | 20.93% |
| Float | 25.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.88 |
| PB Ratio | 4.15 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.65 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -6.39 |
Financial Efficiency
Return on equity (ROE) is -133.79% and return on invested capital (ROIC) is -55.39%.
| Return on Equity (ROE) | -133.79% |
| Return on Assets (ROA) | -35.78% |
| Return on Invested Capital (ROIC) | -55.39% |
| Return on Capital Employed (ROCE) | -115.51% |
| Weighted Average Cost of Capital (WACC) | 8.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 71 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.25 |
Taxes
In the past 12 months, HomeBiogas has paid 35,749 in taxes.
| Income Tax | 35,749 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.12% in the last 52 weeks. The beta is 0.01, so HomeBiogas's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -42.12% |
| 50-Day Moving Average | 84.90 |
| 200-Day Moving Average | 87.85 |
| Relative Strength Index (RSI) | 48.68 |
| Average Volume (20 Days) | 130,070 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HomeBiogas had revenue of ILS 9.03 million and -15.26 million in losses. Loss per share was -0.47.
| Revenue | 9.03M |
| Gross Profit | 3.30M |
| Operating Income | -11.14M |
| Pretax Income | -15.23M |
| Net Income | -15.26M |
| EBITDA | -10.67M |
| EBIT | -11.14M |
| Loss Per Share | -0.47 |
Balance Sheet
The company has 6.74 million in cash and 1.02 million in debt, with a net cash position of 5.71 million or 0.13 per share.
| Cash & Cash Equivalents | 6.74M |
| Total Debt | 1.02M |
| Net Cash | 5.71M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 8.44M |
| Book Value Per Share | 0.23 |
| Working Capital | 5.43M |
Cash Flow
In the last 12 months, operating cash flow was -8.96 million and capital expenditures -1.08 million, giving a free cash flow of -10.04 million.
| Operating Cash Flow | -8.96M |
| Capital Expenditures | -1.08M |
| Depreciation & Amortization | 475,906 |
| Net Borrowing | -272,813 |
| Free Cash Flow | -10.04M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 36.51%, with operating and profit margins of -123.28% and -168.96%.
| Gross Margin | 36.51% |
| Operating Margin | -123.28% |
| Pretax Margin | -168.57% |
| Profit Margin | -168.96% |
| EBITDA Margin | -118.11% |
| EBIT Margin | -123.28% |
| FCF Margin | n/a |
Dividends & Yields
HomeBiogas does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.05% |
| Shareholder Yield | -35.05% |
| Earnings Yield | -43.55% |
| FCF Yield | -28.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HomeBiogas has an Altman Z-Score of -13.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.66 |
| Piotroski F-Score | 3 |